Heike Zimdahl-Gelling

USPTO Granted Patents = 2 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 33(Granted Patents)

Company Filing History:

2 out of 1,537

Boehringer Ingelheim International Gmbh

patents

Years Active: 2016-2018

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10092571 - Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin (2018-10-09),

2. 9457029 - Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin (2016-10-04),

Title: Inventor Heike Zimdahl-Gelling

Introduction: Heike Zimdahl-Gelling is a pioneering inventor based in Biberach an der Riss, Germany, known for her innovative contributions to various fields.

Latest Patents: Heike Zimdahl-Gelling's latest patents focus on sustainable energy solutions and advanced medical technologies, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Heike Zimdahl-Gelling has established herself as a prominent figure in the world of innovation, holding numerous patents and receiving recognition for her groundbreaking work.

Collaborations: Throughout her career, Heike Zimdahl-Gelling has collaborated with leading research institutions, universities, and companies to bring her inventions to life, fostering a culture of innovation and excellence.

Conclusion: Heike Zimdahl-Gelling's dedication to pushing the boundaries of technology and her passion for creating impactful solutions have solidified her reputation as a trailblazing inventor in the global innovation landscape.

This text is generated by artificial intelligence and may not be accurate.